PPARs are transcription factors which regulate lipid and lipoprotein metabo
lism, glucose homeostasis and cellular differentiation. PPAR alpha enhances
fatty acid oxidation whereas PPAR gamma promotes adipogenesis and fatty ac
id storage in adipose tissue. Both PPAR alpha and PPAR gamma improve glucos
e homeostasis. PPAR alpha and PPAR gamma are activated by the pharmacologic
al agents fibrates and glitazones respectively, and by natural fatty acid d
erivatives, including inflammation mediators. PPARs are expressed in the di
fferent cell types of human atherosclerotic lesions where they regulate the
expression of genes involved in the inflammatory response and lipid homeos
tasis. PPARs modulate the recruitment and adhesion of leukocytes and monocy
tes to the atherosclerotic lesion. PPARs furthermore control macrophage lip
id homeostasis through their action on scavenger receptors and by regulatin
g genes involved in the first steps of the reverse cholesterol transport pa
thway. Finally, PPARs regulate genes controlling thrombogenicity associated
with plaque rupture. These observations suggest that PPARs modulate athero
sclerosis development by acting at both metabolic and vascular levels. This
review will essentially focus on the functions of PPAR alpha and PPAR gamm
a in immunoregulation, vascular inflammation and thrombosis associated to a
therosclerosis. J Cardiovasc Risk 8:187-194 (C) 2001 Lippincott Williams &
Wilkins.